Summary of Study ST002991

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001862. The data can be accessed directly via it's Project DOI: 10.21228/M81M8F This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002991
Study TitleMetabolomics studies on human colorectal cancer cell lines
Study SummaryAlthough targeting oxidative phosphorylation (OXPHOS) for cancer treatment is currently impeded due to dose-limiting toxicities, there remain opportunities through combinations that provide therapeutic benefits at doses attainable in patients. On the other hand, while glycolysis-deficient cancers are generally vulnerable to OXPHOS inhibition in preclinical models, the full extent of phenotypical and mechanistic consequences of inhibiting OXPHOS in cancers capable of glycolysis is not yet well understood. We aimed to clarify the response and underlying mechanisms of colorectal cancer (CRC) that commonly exhibit the glycolytic phenotype to OXPHOS inhibition and to identify potential approaches to render such cells more sensitive to OXPHOS inhibitors. The responses of glycolysis-competent CRC cells to targeting OXPHOS were tested using targeted meatbolomics.
Institute
University of Newcastle
Last NameZhao
First NameXiaohong
AddressUniversity Drive, Callaghan, NSW, 2308, Australia
Emailxiaohong.zhao@newcastle.edu.au
Phone61 0466219528
Submit Date2023-11-27
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2025-01-13
Release Version1
Xiaohong Zhao Xiaohong Zhao
https://dx.doi.org/10.21228/M81M8F
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001862
Project DOI:doi: 10.21228/M81M8F
Project Title:DNA replication stress underpins the vulnerability to oxidative phosphorylation inhibition in colorectal cancer
Project Summary:Although targeting oxidative phosphorylation (OXPHOS) for cancer treatment is currently impeded due to dose-limiting toxicities, there remain opportunities through combinations that provide therapeutic benefits at doses attainable in patients. On the other hand, while glycolysis-deficient cancers are generally vulnerable to OXPHOS inhibition in preclinical models, the full extent of phenotypical and mechanistic consequences of inhibiting OXPHOS in cancers capable of glycolysis is not yet well understood. We aimed to clarify the response and underlying mechanisms of colorectal cancer (CRC) that commonly exhibit the glycolytic phenotype to OXPHOS inhibition and to identify potential approaches to render such cells more sensitive to OXPHOS inhibitors.
Institute:The University of Newcastle
Last Name:Zhao
First Name:Xiaohong
Address:University Drive, Callaghan, NSW, 2308, Australia
Email:xiaohong.zhao@newcastle.edu.au
Phone:61 0466219528
  logo